In cancer-associated VTE, apixaban was noninferior to dalteparin for recurrence and did not increase major bleeding

Irbaz Bin Riaz; Ariela L. Marshall; Robert G. Badgett

doi:10.7326/ACPJ202008180-021

In cancer-associated VTE, apixaban was noninferior to dalteparin for recurrence and did not increase major bleeding

Irbaz Bin Riaz
, Ariela L. Marshall
, Robert G. Badgett

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	JC21
Journal	Annals of internal medicine
Volume	173
Issue number	4
DOIs	https://doi.org/10.7326/ACPJ202008180-021
State	Published - Aug 18 2020
Externally published	Yes

Bibliographical note

Funding Information:
Bristol-Myers Squibb–Pfizer Alliance.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publisher link

10.7326/ACPJ202008180-021

Find It

Find It at U of M Libraries

Cite this

@article{6fd2cb46bdbd46e7bc6ff4ca05f8a945,

title = "In cancer-associated VTE, apixaban was noninferior to dalteparin for recurrence and did not increase major bleeding",

author = "Riaz, \{Irbaz Bin\} and Marshall, \{Ariela L.\} and Badgett, \{Robert G.\}",

note = "Funding Information: Bristol-Myers Squibb–Pfizer Alliance.",

year = "2020",

month = aug,

day = "18",

doi = "10.7326/ACPJ202008180-021",

language = "English (US)",

volume = "173",

pages = "JC21",

journal = "Annals of internal medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "4",

}

TY - JOUR

T1 - In cancer-associated VTE, apixaban was noninferior to dalteparin for recurrence and did not increase major bleeding

AU - Riaz, Irbaz Bin

AU - Marshall, Ariela L.

AU - Badgett, Robert G.

N1 - Funding Information: Bristol-Myers Squibb–Pfizer Alliance.

PY - 2020/8/18

Y1 - 2020/8/18

UR - https://www.scopus.com/pages/publications/85089555954

UR - https://www.scopus.com/pages/publications/85089555954#tab=citedBy

U2 - 10.7326/ACPJ202008180-021

DO - 10.7326/ACPJ202008180-021

M3 - Comment/debate

C2 - 32805168

AN - SCOPUS:85089555954

SN - 0003-4819

VL - 173

SP - JC21

JO - Annals of internal medicine

JF - Annals of internal medicine

IS - 4

ER -

In cancer-associated VTE, apixaban was noninferior to dalteparin for recurrence and did not increase major bleeding

Bibliographical note

UN SDGs

Publisher link

Find It

Other files and links

Cite this